Featured Articles

  1. From Extraterrestrial Life To Cancer Research: Engineering Breakthroughs 6/27/2025

    Sometimes the key to making a breakthrough in research, in any field, is to look at the problem differently than anybody has before, explains Delve Therapeutics cofounder and CTO Mike Flanagan, Ph.D.  

  2. What Life Sciences Gets Right (And Misses) About AI 6/25/2025

    Fear of change is a key limiting factor that is slowing the adoption and value of AI across life sciences. It doesn't have to be that way, writes Anastasia Christianson, Ph.D.

  3. Ten To-Do's For Transitioning From Academia To Entrepreneurship 6/23/2025

    Cuts to federal research funding at universities and research organizations are pushing academic scientists into life sciences entrepreneurship. Experts at Sidley offer tips for the transition.

  4. BIO2025: Sanofi R&D, FDA's Martin Makary, Paying For New Therapies 6/20/2025

    BIO was as busy as ever in Boston this year. With more to come soon, here are a few initial thoughts on three events I attended.

  5. A New Prescription For R&D Tax Credit Reporting 6/20/2025

    New IRS requirements for R&D tax credits are coming into effect for tax year 2025. Life sciences companies should prepare for the changes now, explains Sophia Shah, a CPA at Crowe.

  6. Structuring Cross Border China Biotech 'NewCo' Transactions 6/18/2025

    Proper legal structuring is essential when it comes to transferring Chinese biotech intellectual property and clinical assets to form a U.S.-based 'Newco,' explain experts at Orrick.

  7. Using Generative AI For Smarter, Faster, More Predictive Biopharma Ops 6/16/2025

    Experts at PA Consulting offer case studies and advice for using generative AI to improve biopharma manufacturing, mitigate risk, and comply with emerging AI regulations.

  8. EU Launches Strategic Bid to Attract R&D and Investments in Biotech 6/12/2025

    The European Union (EU) is actively courting biotech for economic growth and has launched several initiatives to attract investment and speed innovation to market, explain experts at Sidley.

  9. Winning With The Right Marbles: The Future of Generics 6/11/2025

    After decades of racing to the bottom on pricing, a revolution is coming to the U.S. generics market, writes Yaral Pharma CEO Stephen Beckman.

  10. The Shift From LAL To Recombinant: What Your Lab Should Expect 6/10/2025

    Advocacy for alternatives to animal testing in clinical research is pushing the industry away from animal-based endotoxin testing. Charles River Labs' Nicola Reid lays out the issues to consider.